Vir Biotechnology CEO George Scangos mentioned on Wednesday he’ll retire, ending an itinerant, practically 40-year-career as considered one of biotech’s most recognizable executives.
Scangos, 74, shall be succeeded in April by Marianne De Backer, a longtime pharma government who at present heads pharmaceutical technique at Bayer. She’s going to inherit an organization that rose to prominence through the pandemic by growing the antibody drug sotrovimab and is making an attempt to repeat the success with a sequence of candidates for Covid and different infectious ailments.
window.statGlobal.analytics.fbq = function( eventName, parameters ) { jQuery.ajax( { url: '/wp-json/stat-analytics/v1/facebook-pixel', type: 'POST', data: { event_name: !eventName ? null : eventName, parameters: !parameters ? {} : parameters, source_url: window.location.href }, success: function( data, textStatus, jqXHR ) { //console.log( data ); }, error: function ( jqXHR, textStatus, errorThrown ) { //console.log( jqXHR ); } } ); };
jQuery( window ).on( 'load', function() { if ( !window.bgmpGdpr || window.bgmpGdpr.isOptedOut() ) { return; }
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js');
fbq( 'init', '436331036555416' ); fbq( 'track', 'PageView' );
if ( 'object' === typeof mc4wp && mc4wp.forms ) { mc4wp.forms.on( 'subscribed', function() { // Successful MC4WP newsletter signup AJAX form submission. window.statGlobal.analytics.fbq( 'Lead' ); } ); }
document.addEventListener( 'stat-hubspot-signup-subscribed', () => {
// Successful HubSpot newsletter signup AJAX form submission.
window.statGlobal.analytics.fbq( 'Lead' );
} );
window.statGlobal.analytics.fbq( 'ViewContent' );
} );
Source link
